Elevated serum thyroglobulin as a risk factor of recurrent differentiated thyroid carcinoma after thyroid ablation

Jasminka Alagic-Smailbegovic, Ilhana Setic, Kamenko Sutalo, Mersiha Becirovic & Rusmir Arslanagic
Introduction: Initial management of differentiated thyroid cancer (DTC) is surgical, followed by radioiodine 131I ablation and by the long term administration of thyroid hormon. Recurrent disease does occur in approximately 20–40% of patients. Guidelines for the follow-up management of DTC[for full text, please go to the a.m. URL]